Showing results (1021-1030 of 3,030) with videos related to
Sort By:
Pageof 303
Current Pharmaceutical Biotechnology|June 23, 2007
Using the neurosphere assay to quantify neural stem cells in vivoGregory P Marshall, Brent A Reynolds, Eric D LaywellCurrent Pharmaceutical Biotechnology|June 23, 2007
Adult neurogenesis in mesial temporal lobe epilepsy: a review of recent animal and human studiesY W J Liu, E W Mee, P Bergin, et al.Current Pharmaceutical Biotechnology|December 16, 2006
Arsenic trioxide in hematological malignancies: the new discovery of an ancient drugA Bonati, V Rizzoli, P LunghiCurrent Pharmaceutical Biotechnology|December 16, 2006
Targeting signaling pathways in multiple myelomaCavallo Federica, Palumbo Antonio, Tricot Guido, et al.Current Pharmaceutical Biotechnology|December 16, 2006
Farnesyltransferase inhibitors and rapamycin in the treatment of multiple myelomaMaurizio Zangari, Federica Cavallo, Guido TricotCurrent Pharmaceutical Biotechnology|December 16, 2006
Pharmacological inhibitors of Fatty Acid Synthase (FASN)--catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents?Ruth Lupu, Javier A MenendezCurrent Pharmaceutical Biotechnology|December 16, 2006
Mediterranean dietary traditions for the molecular treatment of human cancer: anti-oncogenic actions of the main olive oil's monounsaturated fatty acid oleic acid (18:1n-9)Javier A Menendez, Ruth LupuCurrent Pharmaceutical Biotechnology|June 13, 2009
Immunogenicity assessment of therapeutic proteins and peptidesArunan Kaliyaperumal, Shuqian JingCurrent Pharmaceutical Biotechnology|June 13, 2009
Application of vibrational spectroscopy to the structural characterization of monoclonal antibody and its aggregateCynthia H Li, Tiansheng LiCurrent Pharmaceutical Biotechnology|June 13, 2009
Effect of additives on protein aggregationHiroyuki Hamada, Tsutomu Arakawa, Kentaro ShirakiPageof 303